Bank Julius Baer & Co. Ltd, Zurich Brainstorm Cell Therapeutics Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$2.92 - $4.19 $12,167 - $17,459	-4,167 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.14 - $4.09 $138 - $179	-44 Reduced 1.04%	4,167 $14,000
Q2 2021 Jul 23, 2021	BUY	$3.01 - $4.01 $132 - $176	44 Added 1.06%	4,211 $16,000
Q1 2021 May 10, 2021	SELL	$3.46 - $7.88 $93 - $212	-27 Reduced 0.64%	4,167 $16,000
Q4 2020 Feb 24, 2021	BUY	$3.99 - $17.73 $107 - $478	27 Added 0.65%	4,194 $19,000
Q4 2020 Feb 12, 2021	SELL	$3.99 - $17.73 $7,980 - $35,460	-2,000 Reduced 32.43%	4,167 $19,000
Q3 2020 Nov 10, 2020	BUY	$11.19 - $16.92 $134 - $203	12 Added 0.19%	6,167 $104,000
Q2 2020 Aug 12, 2020	BUY	$4.42 - $12.66 $8,893 - $25,471	2,012 Added 48.56%	6,155 $69,000
Q1 2020 May 13, 2020	BUY	$4.01 - $8.88 $16,613 - $36,789	4,143 New	4,143 $19,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.